Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 4, 2022
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
[ Thu, Aug 04th 2022
] - WOPRAI
Lawrence Biegelsen Maintained (TNDM) at Buy with Decreased Target to $82 on, Aug 4th, 2022
Lawrence Biegelsen of Wells Fargo, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Buy with Decreased Target from $166 to $82 on, Aug 4th, 2022.
Lawrence has made no other calls on TNDM in the last 4 months.
There are 2 other peers that have a rating on TNDM. Out of the 2 peers that are also analyzing TNDM, 1 agrees with Lawrence's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $110 on, Thursday, May 5th, 2022
This is the rating of the analyst that currently disagrees with Lawrence
- Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $130 on, Tuesday, May 17th, 2022
